Search results
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Digital Journal· 6 days agoAcasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high</ ...
Anxiety: How Forcing Yourself to Chill Out Can Lead to ‘Stresslaxing’
Healthline· 5 days agoStressing out about finding ways to relax can increase anxiety, leading to feeling “stresslaxed.”...